How could Oracle's stock performance lag the S&P 500 affect BlackRock?
BlackRock's stake in Oracle may see reduced valuation amid high AI spending As Oracle's stock performance lags the S&P 500 index, the market valuation of Oracle decreases. Since BlackRock holds a substantial stake in the company, this decline in Oracle's share price directly reduces the market value of BlackRock's holdings. The stock lag is attributed to Oracle's aggressive spending on its AI build-out, which has led to negative free cash flow and the need to raise fresh capital, such as selling $20 billion in stock in the fiscal first quarter of 2027.
- Effect
- Mild negative
- How direct
- Brind's reasoning
- When
- Within weeks
- The story
- Still developing
How it reaches BlackRock
-
As of October 17, 2026, Oracle stock was near $130, down 33% this year, while the S&P 500 returned about 13% through September. The company is increasing its spending on artificial intelligence build-out, with capital expenditures rising sharply.
The full event1independent outlet -
BlackRock holds a substantial stake in Oracle. Therefore, the decline in Oracle's share price directly reduces the market value of BlackRock's investment in the company.
No report states this step directly. Brind drew it from the reporting on each side of it, so treat it as an informed guess.
-
American multinational investment management corporation
Everything about BlackRock
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
- Oracle stock was down 33% this year, while the S&P 500 returned about 13% through September.fool.com
- Capital expenditures surged to $28.5 billion in the fiscal first quarter of 2027.fool.com
- Free cash flow was still negative $5.4 billion in the fiscal first quarter.fool.com
- Oracle sold $20 billion in stock under an at-the-market program in fiscal Q1.fool.com
Why it matters
As a major institutional investor, BlackRock's substantial stake in Oracle means the company's financial health and market perception directly impact its own portfolio performance. The stock lag reflects market concerns over Oracle's ability to translate massive AI infrastructure spending into immediate, positive free cash flow, forcing the company to dilute shareholder value by raising fresh capital.
This situation highlights the tension between long-term strategic investment and short-term shareholder returns. While Oracle's management projects earnings per share to compound at 28% through fiscal 2030, the immediate need to fund its AI build-out through debt and equity is causing current investor hesitation and stock underperformance.
What we don't know yet
- When will Oracle return to positive free cash flow?
- How quickly will the revenue recognition from Oracle's remaining performance obligations ramp up?
What would change this answer
— Other considerations
Beyond this explainer
Explore connected ideas
Each opens in Related concepts: what the web connects to it, with Brind's news on it.
The ideas come from how millions of web pages place them near each other. The questions are Brind's AI reasoning, written only from this explainer and Brind's own reporting.
Who else could feel it
Other possible ripples from the same event.
- CoreWeavePossibleOracle's high spending could reduce competitive pressure on CoreWeave
- NvidiaPossibleOracle's high AI spending could curb demand for Nvidia's chips
- AMDPossibleOracle's financial strain may curb demand for AMD processors
- AmazonPossibleAmazon may gain cloud market share as Oracle faces financial pressure
- MicrosoftPossibleOracle's financial strain could allow Microsoft to capture cloud market share
- Larry EllisonPossibleOracle stock underperformance could reduce the value of Larry Ellison's stake
Reporting
- fool.comYesterday
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.